Skip to content

Clinical trials

Withdrawn Phase 2 Head and Neck Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Head and Neck Neoplasms Phase: Phase 2 Status: Withdrawn Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20061
20093
20102
20111
20132
20161
20182
20192
20202
20212
20222
20231
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn27

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center3
SWOG Cancer Research Network2
University of Chicago2
AHS Cancer Control Alberta1
Adaptimmune1
AstraZeneca1
BioMimetix JV, LLC1
Georgetown University1
Institut Claudius Regaud1
Institut de Cancérologie de la Loire1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Head and Neck Neoplasms27
Squamous Cell Carcinoma of Head and Neck6
Carcinoma, Squamous Cell3
Breast Neoplasms2
Lung Neoplasms2
Neoplasm Metastasis2
Stomach Neoplasms2
Carcinoma1
Carcinoma, Non-Small-Cell Lung1
Colorectal Neoplasms1

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.